Neuropsychiatric adverse drug reactions induced by montelukast impair the quality of life in children with asthma.
Oznur Yilmaz BayerIpek TurktasHacer Ilbilge Ertoy KaragolA. Şebnem Soysal AcarDilek YaparPublished in: The Journal of asthma : official journal of the Association for the Care of Asthma (2020)
Montelukast-induced neuropsychiatric ADRs are more frequent than reported in the literature and negatively impact children's QoL.